Preface: A brief review of N-acetylaspartate

Advances in Experimental Medicine and Biology

Volumn 576, Issue , 2006, Pages

  Moffett, John R ^a   Namboodiri, Aryan M A ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DIPEPTIDE; DRUG DERIVATIVE; N ACETYL 1 ASPARTYLGLUTAMIC ACID; N ACETYLASPARTIC ACID; N-ACETYL-1-ASPARTYLGLUTAMIC ACID; N-ACETYLASPARTATE;

ANIMAL; BIOSYNTHESIS; CANAVAN DISEASE; CHEMISTRY; ENERGY METABOLISM; ENZYMOLOGY; HUMAN; METABOLISM; MYELIN SHEATH; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOLARITY; REVIEW;

ANIMALS; ASPARTIC ACID; CANAVAN DISEASE; DIPEPTIDES; ENERGY METABOLISM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MYELIN SHEATH; NEURONS; OSMOLAR CONCENTRATION;

EID: 33747425613     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Editorial

References (46)

1. H. H. Tallan, S. Moore and W. H. Stein, N-Acetyl-L-aspartic acid in brain. J. Biol. Chem., 219 (1), 257-264 (1956).
2. E. Miyamoto, Y. Kakimoto and I. Sano, Identification of N-acetylaspartylglutamic acid in the bovine brain. J. Neurochem., 13, 999-1003 (1966).
3. R. U. Margolis, S. S. Barkulis and A. Geiger, A comparison between the incorporation of 14C from glucose into N-acetyly-L-aspartic acid and aspartic acid in brain perfusion experiments. J. Neurochem., 5, 379-382 (1960).
4. J. C. McIntosh, J. R. Cooper, Studies on the function of N-acetyl aspartic acid in brain. J. Neurochem., 12 (9), 825-835 (1965).
5. D. L. Taylor, S. E. Davies, T. P. Obrenovitch, J. Urenjak, D. A. Richards, J. B. Clark and L. Symon, Extracellular N-acetylaspartate in the rat brain: in vivo determination of basal levels and changes evoked by high K+. J Neurochem., 62 (6), 2349-2355 (1994).
6. D. L. Taylor, S. E. Davies, T. P. Obrenovitch, M. H. Doheny, P. N. Patsalos, J. B. Clark and L. Symon, Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J Neurochem., 65 (1), 275-281 (1995).
7. S. E. Davies, M. Gotoh, D. A. Richards and T. P. Obrenovitch, Hypoosmolarity induces an increase of extracellular N-acetylaspartate concentration in the rat striatum. Neurochem. Res., 23 (8), 1021-1025 (1998).
8. M. H. Baslow, D. N. Guilfoyle, Effect of N-acetylaspartic acid on the diffusion coefficient of water: a proton magnetic resonance phantom method for measurement of osmolyte-obligated water. Anal. Biochem., 311 (2), 133-138 (2002).
9. M. H. Baslow, Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem. Int., 40 (4), 295-300 (2002).
10. M. H. Baslow, Brain N-acetylaspartate as a molecular water pump and its role in the etiology of canavan disease: a mechanistic explanation. J. Mol. Neurosci., 21 (3), 185-190 (2003).
11. R. L. George, W. Huang, H. A. Naggar, S. B. Smith and V. Ganapathy, Transport of N-acetylaspartate via murine sodium/dicarboxylate cotransporter NaDC3 and expression of this transporter and aspartoacylase II in ocular tissues in mouse. Biochim. Biophys. Acta, 1690 (1), 63-69 (2004).
12. A. F. D'Adamo, L. I. Gidez and F. M. Yatsu, Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp. Brain Res., 5, 267-273 (1968).
13. A. F. D'Adamo, Jr., F. M. Yatsu, Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and the biosynthesis of brain lipids. J. Neurochem., 13 (10), 961-965 (1966).
14. R. Burri, C. Steffen and N. Herschkowitz, N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev. Neurosci., 13, 403-412 (1991).
15. V. Mehta, M. A. Namboodiri, N-acetylaspartate as an acetyl source in the nervous system. Brain Res. Mol. Brain Res., 31 (1-2), 151-157 (1995).
16. G. Chakraborty, P. Mekala, D. Yahya, G. Wu and R. W. Ledeen, Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem., 78 (4), 736-745 (2001).
17. C. N. Madhavarao, P. Arun, J. R. Moffett, S. Suczs, S. Surendran, R. Matalon, J. Garbern, D. Hristova, A. Johnson, W. Jiang and M. A. Namboodiri, Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc. Natl. Acad. Sci. U. S. A, 102 (14), 5221-5226 (5 A.D.).
18. H. C. Buniatian, V. S. Hovhannissian and G. V. Aprikian, The participation of N-acetyl-L-aspartic acid in brain metabolism. J. Neurochem., 12 (8), 695-703 (1965).
19. C. N. Madhavarao, C. Chinopoulos, K. Chandrasekaran and M. A. Namboodiri, Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J. Neurochem., 86 (4), 824-835 (2003).
20. T.B. Patel and J. B.Clark, Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 184 (3), 539-46 (1979).
21. B. Tavazzi, S. Signoretti, G. Lazzarino, A. M. Amorini, R. Delfini, M. Cimatti, A. Marmarou and R. Vagnozzi, Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats. Neurosurgery, 56 (3), 582-589 (2005).
22. S. Signoretti, A. Marmarou, B. Tavazzi, G. Lazzarino, A. Beaumont and R. Vagnozzi, N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J. Neurotrauma, 18 (10), 977-991 (2001).
23. C. Gasparovic, N. Arfai, N. Smid and D. M. Feeney, Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. J. Neurotrauma, 18 (3), 241-246 (2001).
24. T. E. Bates, M. Strangward, J. Keelan, G. P. Davey, P. M. Munro and J. B. Clark, Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport, 7 (8), 1397-1400 (1996).
25. C. Dautry, F. Vaufrey, E. Brouillet, N. Bizat, P. G. Henry, F. Conde, G. Bloch and P. Hantraye, Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J. Cereb. Blood Flow Metab, 20 (5), 789-799 (2000).
26. C. N. Madhavarao, P. Arun, J. R. Moffett, S. Suczs, S. Surendran, R. Matalon, J. Garbern, D. Hristova, A. Johnson, W. Jiang and M. A. Namboodiri, Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc. Natl. Acad. Sci. U. S. A, 102 (14), 5221-5226 (5 A.D.).
27. L. M. Gehl, O. H. Saab, T. Bzdega, B. Wroblewska and J. H. Neale, Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J. Neurochem., 90 (4), 989-997 (2004).
28. C. B. Cangro, M. A. Namboodiri, L. A. Sklar, A. Corigliano-Murphy and J. H. Neale, Immunohistochemistry and biosynthesis of N-acetylaspartylglutamate in spinal sensory ganglia. J. Neurochem., 49, 1579-1588 (1987).
29. P. Leone, C. G. Janson, S. J. McPhee and M. J. During, Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease. Curr. Opin. Mol. Ther., 1 (4), 487-492 (1999).
30. R. Kaul, G. P. Gao, K. Balamurugan and R. Matalon, Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease [see comments]. Nat. Genet., 5, 118-123 (1993).
31. B. J. Zeng, Z. H. Wang, L. A. Ribeiro, P. Leone, R. De Gasperi, S. J. Kim, S. Raghavan, E. Ong, G. M. Pastores and E. H. Kolodny, Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J. Inherit. Metab Dis., 25 (7), 557-570 (2002).
32. A. F. D'Adamo, Jr., J. C. Smith and C. Woiler, The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J. Neurochem., 20 (4), 1275-1278 (1973).
33. R. Matalon, K. Michals and R. Kaul, Canavan disease: from spongy degeneration to molecular analysis. J Pediatr., 127 (4), 511-517 (1995).
34. P. Leone, C. G. Janson, L. Bilaniuk, Z. Wang, F. Sorgi, L. Huang, R. Matalon, R. Kaul, Z. Zeng, A. Freese, S. W. McPhee, E. Mee, M. J. During and L. Bilianuk, Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann. Neurol., 48 (1), 27-38 (2000).
35. L. Pliss, V. J. Balcar, V. Bubenikova, J. Pokorny, T. FitzGibbon and F. St'astny, Morphology and ultrastructure of rat hippocampal formation after i.c.v. administration of N-acetyl-L-aspartyl-L-glutamate. Neurosci., 122 (1), 93-101 (2003).
36. T. Akimitsu, K. Kurisu, R. Hanaya, K. Iida, Y. Kiura, K. Arita, H. Matsubayashi, K. Ishihara, K. Kitada, T. Serikawa and M. Sasa, Epileptic seizures induced by N-acetyl-L-aspartate in rats: in vivo and in vitro studies. Brain Res., 861 (1), 143-150 (2000).
37. H. J. Wittsack, H. Kugel, B. Roth and W. Heindel, Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease. J. Magn Reson. Imaging, 6 (6), 889-893 (1996).
38. M. L. Lai, Y. I. Hsu, S. Ma and C. Y. Yu, Magnetic resonance spectroscopic findings in patients with subcortical ischemic stroke. Chung. Hua. I. Hsueh. Tsa. Chih. (Taipei)., 56 (1), 31-35 (1995).
39. W. E. Klunk, K. Panchalingam, J. Moossy, R. J. McClure and J. W. Pettegrew, N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology, 42, 1578-1585 (1992).
40. P. M. Matthews, F. Andermann and D. L. Arnold, A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology, 40, 985-989 (1990).
41. S. S. Gill, D. G. Thomas, N. Van Bruggen, D. G. Gadian, C. J. Peden, J. D. Bell, I. J. Cox, D. K. Menon, R. A. Iles, D. J. Bryant and et al, Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J. Comput. Assist. Tomogr., 14, 497-504 (1990).
42. C. A. Davie, C. P. Hawkins, G. J. Barker, A. Brennan, P. S. Tofts, D. H. Miller and W. I. McDonald, Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain, 117, 49-58 (1994).
43. D. K. Menon, J. G. Ainsworth, I. J. Cox, R. C. Coker, J. Sargentoni, G. A. Coutts, C. J. Baudouin, A. E. Kocsis and J. R. Harris, Proton MR spectroscopy of the brain in AIDS dementia complex. J. Comput. Assist. Tomogr., 16, 538-542 (1992).
44. D. L. Arnold, P. M. Matthews, G. Francis and J. Antel, Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med., 14, 154-159 (1990).
45. M. K. Harte, S. B. Bachus and G. P. Reynolds, Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophr. Res., 75 (2-3), 303-308 (2005).
46. R. G. Steen, R. J. Ogg, Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease. AJNR Am. J. Neuroradiol., 26 (3), 463-468 (2005).